Armistice Capital »

Inogen shares owned by Armistice Capital

Quarter-by-quarter ownership of Inogen (INGN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Inogen

Tip: Access up to 7 years of quarterly data

All positions including Inogen held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inogen by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.1M 864k 8.17

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Inogen

BlackRock
Vanguard Group
Acadian Asset Management
Camber Capital Management
Armistice Capital
Ameriprise Financial
Dimensional Fund Advisors
Morgan Stanley
Geode Capital Management
DAFNA Capital Management
Royce & Associates
Renaissance Technologies
Prudential Financial
State Street Corporation
Kent Lake PR

View all funds holding Inogen